Report overview
HIV Therapy involves taking a combination of HIV medicines . HIV Therapy is recommended for everyone who has HIV. HIV Therapy cannot cure HIV, but HIV medicines help people with HIV live longer, healthier lives.
This report aims to provide a comprehensive presentation of the global market for HIV Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Therapy. This report contains market size and forecasts of HIV Therapy in global, including the following market information:
Global HIV Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global HIV Therapy Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five HIV Therapy companies in 2022 (%)
The global HIV Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Integrase Inhibitors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of HIV Therapy include ViiV Healthcare, Gilead Sciences, Inc., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, AbbVie Inc. and Genentech, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the HIV Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HIV Therapy Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global HIV Therapy Market Segment Percentages, by Type, 2022 (%)
Integrase Inhibitors
Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Combination HIV Medicines
Others
Global HIV Therapy Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global HIV Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global HIV Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global HIV Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HIV Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies HIV Therapy revenues share in global market, 2022 (%)
Key companies HIV Therapy sales in global market, 2018-2023 (Estimated), (K Units)
Key companies HIV Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ViiV Healthcare
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Merck Sharp & Dohme Corp.
Bristol-Myers Squibb Company
Janssen Pharmaceuticals, Inc.
Boehringer Ingelheim International GmbH
AbbVie Inc.
Genentech, Inc.
Mylan N.V.
Outline of Major Chapters:
Chapter 1: Introduces the definition of HIV Therapy, market overview.
Chapter 2: Global HIV Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of HIV Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of HIV Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global HIV Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
